Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Comparing Remicade (Infliximab) vs. Standard Care in the Treatment of Toxic Epidermal Necrolysis

NCT00372723 is registered in ClinicalTrials.gov with Loyola University as lead sponsor.

NCT NCT00372723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00372723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Comparing Remicade (Infliximab) vs. Standard Care in the Treatment of Toxic Epidermal Necrolysis
Lead sponsor
Loyola University
Phase
Phase 2
Overall status
Withdrawn
Start date
July 31, 2006
Completion date
June 30, 2011
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

toxic epidermal necrolysis